Medication adherence: Whose responsibility is it anyway?
Pharmaceutical manufacturers should feel empowered to lead the charge and improve medication adherence as a way to prevent downstream problems that would impact their organizations.
Pharmaceutical manufacturers should feel empowered to lead the charge and improve medication adherence as a way to prevent downstream problems that would impact their organizations.
The pharmaceutical industry employs chief executive officers, chief financial officers, chief revenue officers and chief talent officers, but pharma has yet to employ a chief adherence officer, singularly tasked with going after pharma’s half-a-trillion-dollar revenue opportunity.
There’s getting patients to take their medications, and then there’s convincing big pharmaceutical companies that they should invest in innovative ways to try to get patients to take their medications. The latter, apparently, is more complicated than it sounds. That’s one thing I gleaned from a conversation with Tom Kottler, the CEO of a digital […]